After eight weeks of oral treatment of scutellarin (50 mg/kg), mice in the 35 mg/kg streptozotocin (STZ)-induced diabetic mouse model had enhanced learning and memory functions, and IL-β and TNF-α levels were reduced. Here, TNF is linked to diabetes mellitus.